- Home
- ETON vs REFI Comparison
ETON vs REFI Comparison
Compare ETON & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ETON | REFI |
|---|---|---|
| Founded | 2017 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 278.8M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ETON | REFI |
|---|---|---|
| Price | $58.61 | $10.68 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $39.33 | N/A |
| AVG Volume (30 Days) | ★ 390.1K | 157.5K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 15.79% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.41 | ★ 0.57 |
| Revenue | ★ $79,950,000.00 | $48,857,628.00 |
| Revenue This Year | $40.90 | $17.47 |
| Revenue Next Year | $47.23 | $0.06 |
| P/E Ratio | $145.10 | ★ $18.61 |
| Revenue Growth | ★ 104.94 | N/A |
| 52 Week Low | $14.27 | $9.69 |
| 52 Week High | $66.37 | $13.49 |
Technical Indicators
Market Signals| Indicator | ETON | REFI |
|---|---|---|
| Relative Strength Index (RSI) | 54.72 | 47.83 |
| Support Level | $15.75 | $10.63 |
| Resistance Level | $66.37 | $10.97 |
| Average True Range (ATR) | 2.74 | 0.23 |
| MACD | -0.44 | -0.04 |
| Stochastic Oscillator | 69.00 | 24.24 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. The Company operates as one operating segment, and its primary investment objective is to provide attractive, risk-adjusted returns for stockholders over time, mainly through consistent current income (dividends and distributions) and secondarily, through capital appreciation. The company operates mainly within the USA itself.